Abstract
Pediatric patients are excluded from most coronavirus disease 2019 (COVID-19) therapeutic trials. We outline a rationale for the inclusion of children in COVID-19 therapeutic trials, which enabled us to include children of all ages in a therapeutic COVID-19 trial at our institution.
Keywords: COVID-19; SARS-CoV-2; clinical trial; ethics; pediatrics.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, clinical trial, Ethics, pediatrics, 【초록키워드】 coronavirus disease, Coronavirus disease 2019, clinical trial, Trial, children, Ethics, pediatrics, Pediatric patients, therapeutic, Patient, age, trials, therapeutic trials, rationale, Inclusion, include, excluded, 【제목키워드】 Importance,
【저자키워드】 COVID-19, SARS-CoV-2, clinical trial, Ethics, pediatrics, 【초록키워드】 coronavirus disease, Coronavirus disease 2019, clinical trial, Trial, children, Ethics, pediatrics, Pediatric patients, therapeutic, Patient, age, trials, therapeutic trials, rationale, Inclusion, include, excluded, 【제목키워드】 Importance,
{{{ 추상적인 }}}
소아 환자는 대부분의 코로나바이러스 질병 2019(COVID-19) 치료 시험에서 제외됩니다. 우리는 COVID-19 치료 시험에 어린이를 포함하는 근거를 설명합니다. 이를 통해 모든 연령대의 어린이를 우리 기관의 치료 COVID-19 시험에 포함할 수 있습니다.
{{ 키워드: }} 코로나19; 사스 코로나바이러스 2; 임상 시험; 윤리학; 소아과.